BioCentury
ARTICLE | Company News

Aeson, Hollis-Eden deal

October 16, 2000 7:00 AM UTC

HEPH acquired an exclusive worldwide sublicense to three Aeson patents covering adrenal steroids. HEPH also acquired a 21 percent equity stake in Aeson in exchange for $2 million in cash and 208,681 s...